Protection from shots like the flu vaccine typically takes a couple of weeks to kick in, so getting one now may offer ...
The Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its ...
"Yes, the FDA and NIH fall under HHS ... analysts at Intron Health see "genuine risk" to vaccine sales in the U.S. GSK and ...
Misconception #1: The flu and COVID-19 vaccines can make you sick. “You aren’t going to get the flu from the flu vaccine. You ...
After an investigation, the agency concluded that a case of muscle weakness in one of Novavax’s trials was actually ALS and ...
The at-home FluMist vaccine will be for patients ages 2 to 49 years old. Patients can place an order online, complete a ...
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, ...
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...
Trump's HHS pick could reshape public health agencies and usher in a new era for vaccines, food, and medicines.
As we head into the holiday season and gather with family and friends, it’s also the time for respiratory diseases to hit ...
The FDA has lifted its clinical hold on Novavax's combined COVID-19 and influenza vaccine trial, finding no link between the ...
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines, the company said on Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback